I’m afraid the short crowd isn’t going anywher
Post# of 148110
All this talk of “somebody knowing something” would be hilarious if it wasn’t so uninformed. Most likely “they” don’t, If “they” do they sure as heck aren’t about to let retail investors in on the secret.
Does CA know some thing that we don’t? Did he buy shares with knowledge only he had access to? Wouldn’t that be insider trading? I think he knows better than that. I hope so anyway as we’ve had that sort of “leadership” before. My guess is he wanted to demonstrate his confidence in LL. It shows good leadership.
The reality when it comes to this stock IS perception. Without any approvals or revenue perception is all we have to go on. Perception made it jump to $10.01 once, maybe it’ll happen again. People have short memories, but I remember regretting not hitting the SELL button when it did.
The Who said it best, “ we won’t get fooled again”
And yes I really do want this company and drug to succeed, but I’m also aware of the vagaries of the market and the disfunction of the Pharma industry and regulatory authorities.